| Entry |
|
| Name |
Safrazine hydrochloride (JAN) |
| Formula |
C11H16N2O2. HCl
|
| Exact mass |
244.0979
|
| Mol weight |
244.72
|
| Structure |

|
| Simcomp |
|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
|
| Efficacy |
Antidepressant, Monoamine oxidase (MAO) inhibitor |
| Target |
|
| Pathway |
| hsa00260 | Glycine, serine and threonine metabolism |
| hsa00330 | Arginine and proline metabolism |
| hsa00982 | Drug metabolism - cytochrome P450 |
|
| Interaction |
|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
D01888 Safrazine hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAO
D01888 Safrazine hydrochloride (JAN)
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 16
1 C8y C 20.9810 -17.4331
2 C8y C 20.9810 -18.8322
3 C8x C 22.1994 -16.7335
4 O2x O 19.6460 -16.9959
5 C8x C 22.1994 -19.5377
6 O2x O 19.6401 -19.2694
7 C8y C 23.4061 -17.4331
8 C1x C 18.8241 -18.1326
9 C8x C 23.4061 -18.8322
10 C1b C 24.6129 -16.7335
11 C1b C 25.8256 -17.4331
12 C1c C 27.0381 -16.7335
13 N1b N 28.2457 -17.4312
14 N1a N 29.4538 -16.7343
15 C1a C 27.0384 -15.3386
16 X Cl 31.4718 -19.2008
BOND 16
1 1 4 1
2 2 5 2
3 2 6 1
4 3 7 1
5 4 8 1
6 5 9 1
7 7 10 1
8 10 11 1
9 11 12 1
10 6 8 1
11 7 9 2
12 12 13 1
13 1 2 1
14 13 14 1
15 12 15 1
16 1 3 2
|